Electron-Beam Method Creates Thousands of Atomic Defects in Crystals
Researchers developed a technique using focused electron beams to rearrange thousands of atoms in a crystal lattice within minutes. The method produces controlled patterns of defects that may exhibit quantum properties. The work builds on earlier single-atom manipulation experiments dating back to 1959.
pravdareport.comA new electron-beam technique allows researchers to create thousands of atomic defects in a crystal lattice in minutes. The approach extends earlier work that had been limited to moving only a few atoms at a time.
1959 physicist Richard Feynman asked what would happen if atoms could be arranged one by one. Subsequent experiments demonstrated single-atom control using scanning tunneling microscopes and electron beams, but those methods remained slow and limited in scale.
Klein et al. report in Nature that a highly focused electron beam can now manipulate thousands of lattice sites rapidly. The resulting defect patterns are described as controllable and potentially useful for quantum devices. The paper appears in the 13 May 2026 issue. It cites prior studies on electron-beam atom manipulation published between 1990 and 2025.
Key Facts
Story Timeline
2 events- 1959
Richard Feynman posed the question of arranging atoms one by one.
1 source@Nature - 13 May 2026
Klein et al. published the electron-beam defect technique in Nature.
1 source@Nature
Potential Impact
- 01
The technique may enable faster fabrication of quantum devices based on engineered crystal defects.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…